XNAS · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Incyte Genomics (INCY) had 1 Form 144 pre-sale notice filed on 2026-05-19. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one fil…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/8/2026 | BAKER BROS. ADVISORS LP | — | OPTION_EXERCISE | -15,000 | — | — |
| 5/8/2026 | BAKER BROS. ADVISORS LP | — | OPTION_EXERCISE | 15,000 | $85 | $1,267,950 |
| 5/4/2026 | Upadhyay Suketu | EVP & Chief Financial Officer | GRANT | 13,171 | — | — |
| 5/4/2026 | Upadhyay Suketu | EVP & Chief Financial Officer | GRANT | 38,429 | — | — |
| 5/4/2026 | Upadhyay Suketu | EVP & Chief Financial Officer | GRANT | 26,343 | — | — |
| 4/17/2026 | CAGNONI PABLO J | President, Global Head of R&D | OPTION_EXERCISE | 6,077 | $64 | $390,447 |
| 4/17/2026 | CAGNONI PABLO J | President, Global Head of R&D | OPTION_EXERCISE | 12,590 | $72 | $905,599 |
| 4/17/2026 | CAGNONI PABLO J | President, Global Head of R&D | SELL | -18,667 | $97 | $1,801,366 |
| 4/17/2026 | CAGNONI PABLO J | President, Global Head of R&D | OPTION_EXERCISE | -6,077 | — | — |
| 4/17/2026 | CAGNONI PABLO J | President, Global Head of R&D | OPTION_EXERCISE | -12,590 | — | — |
| 4/15/2026 | Meury William | Chief Executive Officer | OPTION_EXERCISE | 125,000 | — | — |
| 4/15/2026 | CAGNONI PABLO J | President, Global Head of R&D | GRANT | 27,892 | — | — |
| 4/15/2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | GRANT | 39,049 | — | — |
| 3/31/2026 | BAKER BROS. ADVISORS LP | — | GRANT | 421 | — | — |
| 3/31/2026 | HARRIGAN EDMUND | — | GRANT | 269 | $94 | $25,318 |
| 3/31/2026 | Clancy Paul J | — | GRANT | 265 | $94 | $24,942 |
| 3/25/2026 | Trotta Matteo | EVP, GM, Dermatology US | TAX_WITHHOLD | -537 | $92 | $49,528 |
| 3/17/2026 | CAGNONI PABLO J | President, R&D | OPTION_EXERCISE | 7,166 | $61 | $438,416 |
| 3/17/2026 | CAGNONI PABLO J | President, R&D | OPTION_EXERCISE | 11,501 | $64 | $738,939 |
| 3/17/2026 | CAGNONI PABLO J | President, R&D | SELL | -18,667 | $94 | $1,759,178 |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 5/6/2026 | — | — | — | — | SEC |